Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hyperfine (HYPR)
NASDAQ:HYPR
Hyperfine (HYPR) Stock Price & Analysis
67 Followers
HYPR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.76 - $3.15
Previous Close$1.15
Volume62.53K
Average Volume (3M)134.13K
Market Cap
$82.81M
Enterprise Value$19.61M
Total Cash (Recent Filing)$63.20M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.76
Next Earnings
Aug 08, 2024EPS Estimate
-$0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding72,007,954
10 Day Avg. Volume63,134
30 Day Avg. Volume134,132
Standard Deviation0.24
R-Squared0.05
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.79
Price to Sales (P/S)17.53
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.68
Enterprise Value/Gross Profit4.12
Enterprise Value/Ebitda-0.65
Forecast
1Y Price Target
$1.25Price Target Upside7.76% Upside
Rating ConsensusHold
Number of Analyst Covering2
Hyperfine News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceHYPR’s market cap is currently below its cash level, indicating strong cash reserves.
Future ProspectsPipeline remains robust in 2024 with the launch of upgraded AI software and expected commercial expansion in select EU markets.
Product AdoptionSwoop is now being used in various hospital settings, including the OR, Critical Care unit, Neurology clinics, ED, and Pediatric wards.
Bears Say
Commercialization ChallengesHYPR remains in the early stages of commercialization and may need to overcome many new hurdles including awareness, rep productivity, and expanding clinical indications.
Financial PerformanceCash burn remains high, and management sees the runway into early 2026 while focusing on operational expenses.
Revenue Guidance2024 guidance came below the Street with the company pointing to $12-15M in revenues and cash burn of $40 mil.
---
Ownership Overview
46.29% Insiders
6.65% Mutual Funds
5.39% Other Institutional Investors
41.67% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
HYPR FAQ
What was Hyperfine’s price range in the past 12 months?
Hyperfine lowest stock price was $0.76 and its highest was $3.15 in the past 12 months.
What is Hyperfine’s market cap?
Currently, no data Available
When is Hyperfine’s upcoming earnings report date?
Hyperfine’s upcoming earnings report date is Aug 08, 2024 which is in 12 days.
How were Hyperfine’s earnings last quarter?
Hyperfine released its earnings results on May 13, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.147 by $0.007.
Is Hyperfine overvalued?
According to Wall Street analysts Hyperfine’s price is currently Undervalued.
Does Hyperfine pay dividends?
Hyperfine does not currently pay dividends.
What is Hyperfine’s EPS estimate?
Hyperfine’s EPS estimate is -$0.14.
How many shares outstanding does Hyperfine have?
Hyperfine has 56,952,667 shares outstanding.
What happened to Hyperfine’s price movement after its last earnings report?
Hyperfine reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.147. Following the earnings report the stock price went up 10%.
Which hedge fund is a major shareholder of Hyperfine?
Among the largest hedge funds holding Hyperfine’s share is HealthCor Management, L.P.. It holds Hyperfine’s shares valued at 4M.
---
Hyperfine Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.25 (7.76% Upside)
$1.25 (7.76% Upside)
Blogger Sentiment
Bullish
HYPR Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $2.4K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-57.40%
12-Months-Change
Fundamentals
Return on Equity
-44.51%
Trailing 12-Months
Asset Growth
-30.02%
Trailing 12-Months
Company Description
Hyperfine
HealthCor Catalio Acquisition Corp is a blank check company.
---
HYPR Company Deck
---
HYPR Earnings Call
Q1 2024
0:00 / 0:00
---
HYPR Stock 12 Month Forecast
Average Price Target
$1.25
▲(7.76% Upside)
Technical Analysis
Best Analysts Covering HYPR
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-0.40%
reiterated a buy rating 4 months ago
Copying Neil Chatterji's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -0.40% per trade.
---